117 related articles for article (PubMed ID: 11054022)
1. Increased expression of protease M in ovarian tumors.
Tanimoto H; Underwood LJ; Shigemasa K; Parmley TH; O'Brien TJ
Tumour Biol; 2001; 22(1):11-8. PubMed ID: 11054022
[TBL] [Abstract][Full Text] [Related]
2. Expression of the protease inhibitor antileukoprotease and the serine protease stratum corneum chymotryptic enzyme (SCCE) is coordinated in ovarian tumors.
Shigemasa K; Tanimoto H; Underwood LJ; Parmley TH; Arihiro K; Ohama K; O'Brien TJ
Int J Gynecol Cancer; 2001; 11(6):454-61. PubMed ID: 11906548
[TBL] [Abstract][Full Text] [Related]
3. Differential expression of protease activated receptor 1 (Par1) and pY397FAK in benign and malignant human ovarian tissue samples.
Grisaru-Granovsky S; Salah Z; Maoz M; Pruss D; Beller U; Bar-Shavit R
Int J Cancer; 2005 Jan; 113(3):372-8. PubMed ID: 15455382
[TBL] [Abstract][Full Text] [Related]
4. Overexpression of H-Ryk in mouse fibroblasts confers transforming ability in vitro and in vivo: correlation with up-regulation in epithelial ovarian cancer.
Katso RM; Manek S; Biddolph S; Whittaker R; Charnock MF; Wells M; Ganesan TS
Cancer Res; 1999 May; 59(10):2265-70. PubMed ID: 10344726
[TBL] [Abstract][Full Text] [Related]
5. The transmembrane protease serine (TMPRSS3/TADG-12) D variant: a potential candidate for diagnosis and therapeutic intervention in ovarian cancer.
Sawasaki T; Shigemasa K; Gu L; Beard JB; O'Brien TJ
Tumour Biol; 2004; 25(3):141-8. PubMed ID: 15361711
[TBL] [Abstract][Full Text] [Related]
6. The stratum corneum chymotryptic enzyme that mediates shedding and desquamation of skin cells is highly overexpressed in ovarian tumor cells.
Tanimoto H; Underwood LJ; Shigemasa K; Yan Yan MS; Clarke J; Parmley TH; O'Brien TJ
Cancer; 1999 Nov; 86(10):2074-82. PubMed ID: 10570434
[TBL] [Abstract][Full Text] [Related]
7. Overexpression of testisin, a serine protease expressed by testicular germ cells, in epithelial ovarian tumor cells.
Shigemasa K; Underwood LJ; Beard J; Tanimoto H; Ohama K; Parmley TH; O'Brien TJ
J Soc Gynecol Investig; 2000; 7(6):358-62. PubMed ID: 11111072
[TBL] [Abstract][Full Text] [Related]
8. Increased expression of the RIalpha subunit of the cAMP-dependent protein kinase A is associated with advanced stage ovarian cancer.
McDaid HM; Cairns MT; Atkinson RJ; McAleer S; Harkin DP; Gilmore P; Johnston PG
Br J Cancer; 1999 Feb; 79(5-6):933-9. PubMed ID: 10070893
[TBL] [Abstract][Full Text] [Related]
9. Thrombospondin-1 and -2 messenger RNA expression in epithelial ovarian tumor.
Kodama J; Hashimoto I; Seki N; Hongo A; Yoshinouchi M; Okuda H; Kudo T
Anticancer Res; 2001; 21(4B):2983-7. PubMed ID: 11712798
[TBL] [Abstract][Full Text] [Related]
10. Expression of heparanase, Mdm2, and erbB2 in ovarian cancer.
Ginath S; Menczer J; Friedmann Y; Aingorn H; Aviv A; Tajima K; Dantes A; Glezerman M; Vlodavsky I; Amsterdam A
Int J Oncol; 2001 Jun; 18(6):1133-44. PubMed ID: 11351242
[TBL] [Abstract][Full Text] [Related]
11. Expression of human telomerase subunits in ovarian malignant, borderline and benign tumors.
Kyo S; Kanaya T; Takakura M; Tanaka M; Yamashita A; Inoue H; Inoue M
Int J Cancer; 1999 Mar; 80(6):804-9. PubMed ID: 10074910
[TBL] [Abstract][Full Text] [Related]
12. Differential splicing of KLK5 and KLK7 in epithelial ovarian cancer produces novel variants with potential as cancer biomarkers.
Dong Y; Kaushal A; Brattsand M; Nicklin J; Clements JA
Clin Cancer Res; 2003 May; 9(5):1710-20. PubMed ID: 12738725
[TBL] [Abstract][Full Text] [Related]
13. The matrix metalloprotease pump-1 (MMP-7, Matrilysin): A candidate marker/target for ovarian cancer detection and treatment.
Tanimoto H; Underwood LJ; Shigemasa K; Parmley TH; Wang Y; Yan Y; Clarke J; O'Brien TJ
Tumour Biol; 1999; 20(2):88-98. PubMed ID: 10050107
[TBL] [Abstract][Full Text] [Related]
14. A novel protease homolog differentially expressed in breast and ovarian cancer.
Anisowicz A; Sotiropoulou G; Stenman G; Mok SC; Sager R
Mol Med; 1996 Sep; 2(5):624-36. PubMed ID: 8898378
[TBL] [Abstract][Full Text] [Related]
15. Hepsin, a cell surface serine protease identified in hepatoma cells, is overexpressed in ovarian cancer.
Tanimoto H; Yan Y; Clarke J; Korourian S; Shigemasa K; Parmley TH; Parham GP; O'Brien TJ
Cancer Res; 1997 Jul; 57(14):2884-7. PubMed ID: 9230195
[TBL] [Abstract][Full Text] [Related]
16. Increasing expression of serine protease matriptase in ovarian tumors: tissue microarray analysis of immunostaining score with clinicopathological parameters.
Jin JS; Hsieh DS; Loh SH; Chen A; Yao CW; Yen CY
Mod Pathol; 2006 Mar; 19(3):447-52. PubMed ID: 16439987
[TBL] [Abstract][Full Text] [Related]
17. Wilms tumor gene protein 1 is associated with ovarian cancer metastasis and modulates cell invasion.
Barbolina MV; Adley BP; Shea LD; Stack MS
Cancer; 2008 Apr; 112(7):1632-41. PubMed ID: 18260155
[TBL] [Abstract][Full Text] [Related]
18. Human ovarian tumors express gamma-glutamyl transpeptidase.
Hanigan MH; Frierson HF; Brown JE; Lovell MA; Taylor PT
Cancer Res; 1994 Jan; 54(1):286-90. PubMed ID: 7903206
[TBL] [Abstract][Full Text] [Related]
19. Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma.
Elloul S; Elstrand MB; Nesland JM; Tropé CG; Kvalheim G; Goldberg I; Reich R; Davidson B
Cancer; 2005 Apr; 103(8):1631-43. PubMed ID: 15742334
[TBL] [Abstract][Full Text] [Related]
20. Expression of 5alpha-reductases in human epithelial ovarian cancer: its correlation with androgen receptor status.
Akahira JI; Suzuki T; Ito K; Darnel AD; Moriya T; Sato S; Yaegashi N; Okamura K; Sasano H
Jpn J Cancer Res; 2001 Sep; 92(9):926-32. PubMed ID: 11572759
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
